Latest Articles
Study Identifies Unique Genomic Subgroups and Mutational Patterns in Rare Aggressive Endometrial Cancer - geneonline.com
Study Identifies Unique Genomic Subgroups and Mutational Patterns in Rare Aggressive Endometrial Cancer geneonline.com
Published: Oct. 9, 2025, 2:08 p.m.
Distinct genomic subgroups and mutational patterns in undifferentiated/dedifferentiated endometrial carcinoma - BMC Cancer
Distinct genomic subgroups and mutational patterns in undifferentiated/dedifferentiated endometrial carcinoma BMC Cancer
Published: Oct. 9, 2025, 1:10 p.m.
Mutation profile and molecular heterogeneity in mismatch repair deficient endometrial carcinoma - Frontiers
Mutation profile and molecular heterogeneity in mismatch repair deficient endometrial carcinoma Frontiers
Published: Sept. 25, 2025, 5:47 p.m.
Polymerase Mutations Shape Distinct Cancer Risks - Conexiant
Polymerase Mutations Shape Distinct Cancer Risks Conexiant
Published: Aug. 28, 2025, 4:15 p.m.
Israeli sperm donor’s genetic mutation prompts urgent testing call - www.israelhayom.com
Israeli sperm donor’s genetic mutation prompts urgent testing call www.israelhayom.com
Published: June 5, 2025, 6:27 a.m.
Follow-up of hereditary endometrial carcinoma caused by MLH3 gene mutation: a case report - Frontiers
Follow-up of hereditary endometrial carcinoma caused by MLH3 gene mutation: a case report Frontiers
Published: April 7, 2025, 3:32 p.m.
Biocartis Launches qPCR POLE/POLD1 Mutational Assay - Oncology Nursing News
Biocartis Launches qPCR POLE/POLD1 Mutational Assay Oncology Nursing News
Published: April 4, 2025, 2:04 p.m.
Press Release Biocartis NV: Biocartis Announces Launch of the Brand-New Idylla™ POLE-POLD1 Mutation Assay - GlobeNewswire
Press Release Biocartis NV: Biocartis Announces Launch of the Brand-New Idylla™ POLE-POLD1 Mutation Assay GlobeNewswire
Published: April 2, 2025, 5:01 a.m.
Press Release Biocartis NV: Biocartis Announces Launch of the Brand-New Idylla™ POLE-POLD1 Mutation Assay - TradingView
Press Release Biocartis NV: Biocartis Announces Launch of the Brand-New Idylla™ POLE-POLD1 Mutation Assay TradingView
Published: April 2, 2025, 5 a.m.
PPP2R1A Mutations Associated With Prolonged OS in High-Risk Endometrial Cancer - OncLive
PPP2R1A Mutations Associated With Prolonged OS in High-Risk Endometrial Cancer OncLive
Published: Jan. 31, 2025, 8:48 p.m.
Link copied to clipboard!